|
KCTD10 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.33066907387547E-16 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.94460061573454E-11 |
| Normal-vs-Stage2 |
2.360700E-04 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
3.917000E-03 |
| Stage1-vs-Stage2 |
3.256200E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
2.835800E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
8.636000E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.81077375316363E-13 |
| Normal-vs-AfricanAmerican |
3.41720000074375E-08 |
| Normal-vs-Asian |
1.192110E-02 |
| Caucasian-vs-AfricanAmerican |
6.652200E-01 |
| Caucasian-vs-Asian |
1.491180E-01 |
| AfricanAmerican-vs-Asian |
2.935000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.44189999945677E-07 |
| Normal-vs-Female |
1.4104994949804E-10 |
| Male-vs-Female |
8.575600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.97640000000022E-05 |
| Normal-vs-Extreme_Weight |
3.01020000037511E-08 |
| Normal-vs-Obese |
5.006400E-04 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
3.865200E-01 |
| Normal_Weight-vs-Obese |
1.057150E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
2.332800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.73460001496562E-09 |
| Normal-vs-Age(41-60Yrs) |
3.93150000332909E-08 |
| Normal-vs-Age(61-80Yrs) |
1.50310000002207E-08 |
| Normal-vs-Age(81-100Yrs) |
3.613000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.920400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.750300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.283000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.746400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.946800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.784600E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
3.94810000003964E-06 |
| Normal-vs-Grade 3 |
8.25349999455938E-08 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
4.004000E-01 |
| Grade 2-vs-Grade 4 |
3.94810000003964E-06 |
| Grade 3-vs-Grade 4 |
8.25349999455938E-08 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.24045218541369E-12 |
| Normal-vs-N1 |
1.867690E-02 |
| N0-vs-N1 |
9.602600E-01 |
|
|